H Schouten
About
In The Last Decade
H Schouten
6 papers receiving 81 citations
Peers
Comparison fields: 5 of 27
- Oncology 53
- Pathology and Forensic Medicine 38
- Genetics 23
- Hematology 22
- Molecular Biology 12
Countries citing papers authored by H Schouten
This map shows the geographic impact of H Schouten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Schouten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Schouten more than expected).
Fields of papers citing papers by H Schouten
This network shows the impact of papers produced by H Schouten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Schouten. The network helps show where H Schouten may publish in the future.
Co-authorship network of co-authors of H Schouten
This figure shows the co-authorship network connecting the top 25 collaborators of H Schouten. A scholar is included among the top collaborators of H Schouten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Schouten. H Schouten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 34 | |
| 2 | Myeloproliferative neoplasia: a review of clinical criteria and treatment. | 15 |
| 3 | Cytogenetic risk group and cytogenetic response predict outcome of patients with poor-risk mds and secondary aml treated with intensive chemotherapy and stem cell transplantation in a joint study (CRIANT) of the EORTC, EBMT, SAKK, HOVON and GIMEMA leukemia groups | 1 |
| 4 | 12 | |
| 5 | 6 | |
| 6 | Multidrug resistance mediated by P-glycoprotein in haematological malignancies. | 13 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.